Bupropion Hydrochloride
Product Images NDC 53002-2508

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 53002-2508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Bupropion Hydrochloride. (Image 1)

The Structural Formula Bupropion Hydrochloride. (Image 1)
Chemical structure of bupropion hydrochloride showing a chlorophenyl group attached to a tert-butylamino ketone moiety with the hydrochloride component indicated.*
FDA Label Image

Label Image (Lbl530022508)

Label Image (Lbl530022508)
Bupropion Hydrochloride 30 mg extended-release tablets in a label showing 30 tablets of Bupropion-XL 24HR by RPK Pharmaceuticals, Inc. The label includes drug name, strength, dosage form, dose instructions to take one tablet daily or as directed, and prescription details with placeholder text for patient and prescriber information. The label also includes lot number, expiration date, barcode, and other regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.